Regeneron said it is pausing enrollment of hospitalized COVID-19 patients receiving mechanical ventilation or intense oxygen after the independent monitoring committee observed “a potential safety signal and an unfavorable risk/benefit profile at this time.”
The monitoring board recommended collecting additional data on the patients already enrolled.
Earlier this month, a different monitoring board recommended pausing enrollment in a study testing an Eli Lilly antibody drug to investigate a possible safety issue in hospitalized patients.
NIAID Director Anthony FauciListening to experts isn't perfect, but ignoring them is far worse Fauci: Maybe 2022 before US sees 'some semblances of normality' Fauci expresses support for national mask mandate MORE this week said treatment is all about timing; dexamethasone and other steroids can help with severely ill patients on ventilation, as can the antiviral drug remdesivir. Studies with experimental antibody treatments, on the other hand, suggest they are most effective when given on an outpatient basis to someone with mild symptoms
Будем ждать подробностей.